Myeloproliferative disorder Clinical Trials
Conditions / Myeloproliferative disorder
Delta Trials indexes 21 clinical trials for Myeloproliferative disorder in its publicly accessible dataset. Of these, 3 enrolling participants at this time and 16 trials have reached completion. This research takes place spanning 35 research sites around the world. An additional 2 trials are in preparatory or other active non-recruiting stages. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity has changed over time.
Trial Status
21
Total Trials
3
Recruiting
16
Completed
2
Other Active
0
Terminated since 2020
35
Study Locations
Browse by location (35 total)
- New York, United States 5 trialsAll trials in New York, United States
- Chicago, United States 3 trialsAll trials in Chicago, United States
- Boston, United States 2 trialsAll trials in Boston, United States
- Angers, France 2 trialsAll trials in Angers, France
- Brest, France 2 trialsAll trials in Brest, France
- Bruges, Belgium 1 trialAll trials in Bruges, Belgium
- Grand Rapids, United States 1 trialAll trials in Grand Rapids, United States
- Stanford, United States 1 trialAll trials in Stanford, United States
- Houston, United States 1 trialAll trials in Houston, United States
- Bethesda, United States 1 trialAll trials in Bethesda, United States
- Douarnenez, France 1 trialAll trials in Douarnenez, France
- Brussels, Belgium 1 trialAll trials in Brussels, Belgium
- Nîmes, France 1 trialAll trials in Nîmes, France
- Nîmes, France 1 trialAll trials in Nîmes, France
- Nîmes, France 1 trialAll trials in Nîmes, France
- Graz, Austria 1 trialAll trials in Graz, Austria
- Rockville Centre, United States 1 trialAll trials in Rockville Centre, United States
- Yvoir, Belgium 1 trialAll trials in Yvoir, Belgium
- Nantes, France 1 trialAll trials in Nantes, France
- Rennes, France 1 trialAll trials in Rennes, France